If a prescriber documents a specific medical need for a patient, such as an allergy to an inactive ingredient in the brand-name product, compounding may still be permissible on a case-by-case basis
Nausea, constipation, diarrhea, fatigue, and injection-site reactions usually mild and most noticeable after dose increases
This research is progressing to a phase 3 clinical trial of this approach in Parkinson Disease patients (ClinicalTrials.gov Identifier: NCT04232969)
Starter plans typically cover lower doses appropriate for the initial titration period
[1] [5] However, this does not mean alcohol consumption is without risk for patients using this medication
The standard dosing protocol puts most women well beyond that fertility-restoration threshold within the first few months of treatment